Spatially resolved multiomics reveals the self-enforcing property of the leading-edge multicellular ecosystem of head and neck cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41512018.
- Also identified by DOI 10.1073/pnas.2519474123 and PMC identifier 12799181.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Head and neck squamous cell carcinoma (HNSCC) involves aggressive invasion at the tumor-host interface, particularly at the leading edge. However, the mechanisms sustaining this invasive front remain unclear. Here, we performed spatially resolved multiomics profiling to characterize the leading-edge multicellular ecosystem (LEMCE) of HNSCC. We identified a set of twelve autocrine ligands, including TGFB1, ICAM1, and TNC, that support a stable invasive transcriptional state. Impaired fatty acid (FA) degradation in this region enhances autocrine ligands and amplifies proinvasive gene expression. Spatial single-cell analysis revealed that the specific resident cells in the LEMCE, which exhibited increased expression of autocrine ligands and impaired FA degradation, participated in a fibroblast-macrophage-T cell interaction circuit involving MMP1<sup>+</sup> fibroblasts and C1QC<sup>+</sup>/SPP1<sup>+</sup> macrophages, followed by interactions between C1QC<sup>+</sup> macrophages and cytotoxic T cells. These interactions may contribute to the structural organization and immunosuppressive features of the LEMCE. Therapeutically, targeting this niche via a combination of autocrine cytokine blockade, FA metabolic restoration, and PD-1 immune checkpoint inhibition suppressed invasion, reduced metastasis, and prolonged survival in mouse models. Our findings define the LEMCE as a self-reinforcing invasive and immunosuppressive niche and highlight its potential as a targetable vulnerability in HNSCC.
Medical subject headings
- Head and Neck Neoplasms
- Squamous Cell Carcinoma of Head and Neck